← Research library

Bemitil, piracetam and a multicomponent formula at 4,500 m

Comparison in people · 2014

What was studied
60 healthy men aged 20–28 in five groups of 12; each group compared one intervention with placebo in a crossover.
Main finding
The seven-ingredient H1 formula yielded 207 ± 14 W in simulated altitude versus 183 ± 9 W with placebo. Bemitil alone yielded 187 ± 12 W.

Related evidence maps: Sports performance ↗ · Military & occupational ↗

Reported findings and study design

The seven-ingredient H1 formula yielded 207 ± 14 W in simulated altitude versus 183 ± 9 W with placebo. Bemitil alone yielded 187 ± 12 W.

Chamber ascent to 4,500 m. Half of each group received placebo first. Exposures were 2–3 weeks apart and the intervention was taken one hour before ascent.

Population or model 60 healthy men aged 20–28 in five groups of 12; each group compared one intervention with placebo in a crossover.

Dose, route and schedule

Piracetam 800 mg, Bemitil 250 mg, or amtizol succinate 200 mg as single agents. H1 combined piracetam 800 mg, Bemitil 250 mg, Aerovit one tablet, riboxin 400 mg, methionine 500 mg, glutamic acid 500 mg and Panangin one tablet. H2 used the last five ingredients without piracetam or Bemitil.

Protocol source ↗ · Volume II monograph text and Tables 44–45; earlier individual report not located.

Results · Volume II monograph text and Tables 44–45; earlier individual report not located.
MeasureResultComparison, timing and statistics
H1 · cycling workload at 170 bpm207 ± 14 W vs 183 ± 9 W with placebop<0.05 as marked
Bemitil · cycling workload at 170 bpm187 ± 12 W vs 183 ± 9 W with placeboNo significance marking in Table 44.
Bemitil · post-exercise lactate132 ± 7% of normoxic value vs 161 ± 6% with placebop<0.05 as marked
Table 44 · performance in hypoxia
Table 44 · performance in hypoxia
ConditionMental task indexTracking errorsTask failuresPWC₁₇₀ (W)Myocardial tolerance index
Baseline100 ± 476 ± 77 ± 1250 ± 1239 ± 3
Placebo81 ± 6101 ± 1215 ± 4183 ± 934 ± 2
Piracetam86 ± 694 ± 1313 ± 4190 ± 1138 ± 3*
Bemitil90 ± 6*103 ± 1313 ± 2187 ± 1233 ± 3
Amtizol88 ± 784 ± 6*9 ± 2*187 ± 1033 ± 2
H284 ± 6130 ± 16*21 ± 5*188 ± 1037 ± 2*
H193 ± 4*84 ± 8*10 ± 1*207 ± 14*52 ± 5*

M ± m. * p<0.05 versus placebo as printed. More tracking errors or task failures indicate worse performance.

Table 45 · metabolic measures (% of normoxia)
Table 45 · metabolic measures (% of normoxia)
ConditionGlucoseLactatePyruvateLactate/pyruvate index
Placebo89 ± 3161 ± 6134 ± 12120 ± 5
Piracetam91 ± 4135 ± 14*124 ± 9109 ± 4
Bemitil97 ± 3*132 ± 7*121 ± 7*109 ± 5
Amtizol92 ± 5135 ± 7*129 ± 11105 ± 5*
H298 ± 4*138 ± 7*143 ± 897 ± 4*
H1105 ± 5*141 ± 12*159 ± 10*89 ± 6*

Blood drawn immediately after exercise. M ± m. * p<0.05 versus placebo as printed.

A short chamber experiment with physiological and task outcomes. The 60 volunteers are outside the historical cohort count.

Source for these results ↗ · Reviewed 2026-11-17

Study limitations and source details

Study limitations

  • The H1 group had 12 participants and tested seven ingredients together. Effects cannot be assigned to individual ingredients.
  • Masking, harms and overlap with related historical reports remain unresolved.

Source details

Human experiment in FMBA monograph · Volume II monograph text and Tables 44–45; earlier individual report not located.

Volume II monograph text and Tables 44–45; earlier individual report not located.

Reported methods, results and evidence limitations

Sources checked

Added to the library

Citation

Human comparative studyFull text available

N. N. Karkishchenko, V. V. Uyba, V. N. Karkishchenko, E. B. Shustov, K. V. Kotenko, S. V. Okovityi. Bemitil, piracetam and a multicomponent formula at 4,500 m Essays on Sports Pharmacology, Volume II: Vectors of Pharmacoprotection, pp. 210–213, Tables 44–45

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards